Related by context. All words. (Click for frequent words.) 68 Rylomine TM 59 Phase 1a clinical 58 novel oral anticoagulant 56 5 FU CVC 56 ColorectAlert TM 56 Pmi Group Inc 56 randomized Phase IIb 56 Phase III ADT 56 CONBRIZA 56 intranasal formulation 56 Zensana TM 55 oxymorphone ER 55 ruxolitinib 55 PREOS R 55 pharmacokinetic equivalence 55 phase IIa clinical 55 pivotal bioequivalence 55 successfully commercialize Iluvien 55 Alvesco R 54 midstage clinical 54 VITAL Trial 54 Hematide ™ peginesatide 54 PRIMO CABG 54 Targretin capsules 54 subcutaneous methylnaltrexone 54 NP2 Enkephalin 54 PFO migraine 54 initiated Phase Ib 54 Phase IIb III 54 EGS# 54 phase IIb III 53 Zemplar Capsules 53 Pmi Group Inc. 53 CLIRS trial 53 fidaxomicin Phase 53 NasalFent 53 XIAPEX 53 HuCAL antibodies 53 adenosine injection 53 regorafenib 53 ACOMPLIA R 53 Relivar 53 EDEMA3 53 Phase #/#a 53 Phase Ib study 53 CYCLOSET 53 MAA submission 53 AERx iDMS 53 CHAMPION PCI 53 VEGF inhibitor 53 PF # [002] 53 TRANSDUR Bupivacaine 53 BEMA TM Fentanyl 53 UPLYSO 53 EVIZON ™ 53 CIP TRAMADOL ER 53 bioequivalency 53 Zenvia ™ 53 dose escalation Phase 53 ARIKACE ™ 53 Cand5 52 Phase IIIb clinical 52 phase IIb trial 52 MEND CABG II 52 deforolimus 52 lorvotuzumab mertansine 52 BiDil XR 52 QTinno TM 52 Plenaxis TM 52 Neuromodulation System 52 Phase IIA 52 Zavesca r 52 elotuzumab 52 Actimmune ® 52 CCR9 antagonist 52 rALLy trial 52 Abstral ® 52 Memryte 52 delivery polymer matrix 52 Firazyr 52 CRMD# 52 phase IIa 52 LCP AtorFen 52 MAGE A3 ASCI 52 efficacy endpoint 52 transmucosal delivery system 52 vinorelbine tartrate 52 AeroLEF TM 52 Trofex 52 Prosaptide 52 cannabinor 52 Kosan dependence 52 rhThrombin 52 GLP toxicology studies 52 JAK inhibitor 52 PDE4 inhibitor 52 Novolimus 52 SAR# [004] 52 recurrent herpes labialis 52 REMINYL ® 52 Phase III TRIST 52 Q#IR 52 Glybera R 52 omacetaxine mepesuccinate 52 Benlysta belimumab 52 QVAR 52 Fentanyl TAIFUN R 52 Somatuline R Autogel R 52 Anturol TM 51 Ventavis ® 51 FluINsure 51 macitentan 51 BrachySil TM 51 Zegerid OTC 51 Evoltra ® 51 phase IIb 51 statistically significant efficacy 51 Evoltra 51 PANVAC VF 51 Troxatyl 51 glucokinase activator 51 Spiegelmer ® 51 dexanabinol 51 PSMA ADC 51 B. Lynne Parshall 51 EndoTAG TM 51 SinuNase ™ 51 TOLAMBA 51 BNC# 51 Biologic License Application BLA 51 epinastine 51 brivaracetam 51 MADIT 51 midstage trials 51 SPRIX ® 51 preclinical efficacy 51 REVEAL Registry 51 TRIST 51 MERLIN TIMI 51 Allovectin 7 51 Aerovant 51 balsalazide tablet 51 oral taxane 51 Aztreonam 51 MoxDuo 51 Phase Ib clinical 51 budesonide MMX Phase III 51 DCCR 51 Flutiform TM 51 VersaFilm 51 SEPET TM 51 Retisert 51 hoFH 51 POSIDUR TM 51 OvaRex ® MAb 51 HuMax EGFr 51 Phase #b/#a 51 PRESEPT 51 inhaled AAT 51 oral ridaforolimus 51 riociguat 51 QTinno ™ 51 Proellex TM 51 elacytarabine 51 Intraject 51 Phase IIIB IV 51 bevasiranib 51 PD2i Analyzer 51 sterile lidocaine patch 51 Phase 2a clinical trials 51 vidofludimus 51 ABSORB trial 51 MIST II 51 Corporation TSX.V PMV 51 subcutaneous formulation 50 Tracleer R 50 confirmatory Phase III 50 MEND CABG 50 mertansine 50 IND submission 50 dose escalation clinical 50 DDP# 50 SCIB1 50 Multiple Ascending Dose 50 liposomal formulation 50 Phase III confirmatory 50 Shire BioChem Inc. 50 ospemifene 50 vosaroxin 50 cathepsin K inhibitor 50 TroVax ® 50 ACAPODENE 50 OvaRex 50 BioNumerik 50 clevidipine 50 phase IIb study 50 Phase #b/#a trial 50 multicenter Phase II 50 Dr. Fahar Merchant 50 tecarfarin 50 phase Ib 50 lumiliximab 50 ularitide 50 Genz # 50 EDEMA3 trial 50 Androgel R 50 Toraymyxin TM 50 PLAVIX ® 50 Anavex #-# 50 intranasal insulin 50 ALN VSP Phase 50 OncoVEX 50 Oncotype DX colon cancer 50 Solorel 50 Phase 1b trial 50 MethyPatch 50 ONCONASE R 50 Cloretazine 50 Evamist TM 50 rEEG 50 HDL Selective Delipidation 50 PSN# [001] 50 Cinquil 50 phase IIb clinical 50 Group Inc PMI.N 50 analgesic efficacy 50 OMNARIS HFA 50 gepirone ER 50 zileuton CR 50 EmbraceAC 50 CytoFabTM 50 Cipralex ® 50 Panzem R NCD 50 HQK 50 OMS#HP 50 CLIRS 50 faropenem 50 Corlux 50 desvenlafaxine succinate 50 methylnaltrexone 50 PMA submission 50 AVADO 50 BLA filing 50 Hedgehog antagonist 50 Inc. NASDAQ ICGN 50 cobiprostone 50 HuMax TAC 50 GRN# 50 DermaVir Patch 50 Plicera 50 visit www.genenews.com 50 Inc NGSX 50 oral rivaroxaban 50 Phase #b/#a clinical 50 ponatinib 50 Nanobody R 50 Azedra ™ 49 APEX PD 49 Exherin TM 49 Mesafem 49 BRIM3 49 oral methylnaltrexone 49 TLK# 49 SNT MC# 49 docetaxel emulsion 49 MyVax personalized immunotherapy 49 rALLy clinical trial 49 atacicept 49 Tyrima 49 Phase 2a trial 49 TRX1 49 Pafuramidine 49 Phase 1b clinical 49 confirmatory clinical 49 brentuximab vedotin SGN 49 Bicifadine 49 Vectibix panitumumab 49 Excellagen 49 Solorel TM 49 cystinosis patients 49 LUMINATE 49 Solzira 49 midstage clinical trial 49 Amoxicillin PULSYS Phase III 49 Dendreon Provenge 49 SEASONIQUE 49 WILEX 49 postapproval 49 Stimuvax R 49 ALN HTT 49 elagolix 49 Solazed 49 lintuzumab 49 #I TM# 49 Archexin 49 DepoMed 49 OnDose 49 Cleviprex TM clevidipine 49 Intergroup Exemestane Study 49 OVATURE 49 Capesaris 49 Resolute DES 49 PHX# 49 GENASIS clinical 49 FlutiformTM 49 clonidine hydrochloride 49 drug tesmilifene 49 IPL# 49 oral prodrug 49 OncoVex 49 EXPLORE Xa 49 HalcyGen 49 initiate Phase 2b 49 Liposomal Grb 2 49 oxaliplatin Eloxatin 49 RAPTIVA 49 CRLX# 49 Endeavor DES 49 ATL# [001] 49 Annamycin 49 TransVax tm 49 SNS# T 49 Onconase 49 mg/m2 cohort 49 alvespimycin 49 histamine dihydrochloride 49 randomized controlled multicenter 49 punctal plug delivery 49 Urocortin 2 49 QTinno 49 hematological tumors 49 Tarceva TM 49 Kahalalide F 49 IIa trial 49 nalbuphine ER 49 dermaPACE ™ 49 xanthine oxidase inhibitor 49 TNF alpha inhibitor 49 Phase lll 49 Urocidin 49 BrachySil 49 proprietary transdermal patch 49 XOPENEX Inhalation Solution 49 Preotact 49 ChronVac C 49 AIM HIGH 49 orBec 49 forodesine 49 therapeutic monoclonal antibody 49 Granted Orphan Drug 49 LO LOESTRIN FE 49 initiate Phase 1b 48 receptor tyrosine kinase inhibitor 48 Receives Milestone Payment 48 tolevamer 48 Tyzeka Sebivo 48 Pyridorin 48 Ophena 48 Prestara 48 TOCOSOL 48 Hedgehog inhibitor 48 COSIRA trial 48 OvaRex R 48 Nasdaq OPTR 48 Androxal TM 48 HGS ETR2 48 DXL# 48 Gralise 48 GOUT 48 naltrexone SR 48 GALNS 48 generic Lovenox 48 Somatuline Depot 48 randomized blinded 48 Referenced EEG ® 48 alemtuzumab MS 48 Cloretazine R 48 TKM Ebola 48 unblinding 48 CIMZIA ™ 48 AIR# [001] 48 Menerba 48 NEBIDO 48 Numoda 48 Phase IIb clinical trials 48 AMEVIVE 48 R#/MEM # 48 INT# [002] 48 PROactive study 48 ICON7 48 novel histone deacetylase 48 NEVO ™ 48 PharmFilm 48 HIV coinfected 48 GLP1 agonist 48 injectable formulations 48 PREGNANT Study 48 BRAF inhibitors 48 Removab 48 MONOVISC 48 tanespimycin 48 Bifeprunox 48 TransMID 48 arbaclofen 48 Aplidin 48 Toremifene 48 IND enabling 48 NADiA ProsVue 48 sitaxsentan 48 Levadex 48 Angiox ® 48 ADAGIO study 48 Phase IIIb 48 BBI# 48 UVIDEM 48 Enhanze Technology 48 MGN# 48 Bellicum 48 Platinum Chromium 48 LEP ETU 48 budesonide foam 48 oral talactoferrin 48 vitro ADME 48 GRNVAC1 48 FIRMAGON R 48 TRO# 48 BLA submission 48 Dextofisopam 48 Ofirmev 48 PDE# inhibitors 48 Apoptone 48 ganaxolone 48 PEP# [003] 48 relapsed MCL 48 GLPG# 48 Cimzia TM 48 oral PTH 48 systemic RNAi 48 Oncogenex 48 Kirsten Drejer 48 everolimus eluting stents 48 generation PNP inhibitor 48 tipranavir r 48 LymphoStat B TM 48 Thorough QT 48 tropism testing 48 Phase 2b kidney transplant 48 Mipomersen 48 immunotherapeutic vaccine 48 initiate Phase IIa 48 schizophrenia CIAS 48 CAPHOSOL 48 Tesmilifene 48 DURIN TM 48 Phase III psoriasis 48 Eligard ® 48 nanopharmaceutical 48 Specifid 48 Augment Injectable 48 CCX# 48 ReN# stem cell 48 LibiGel NDA 48 CyPath ® 47 RLY# 47 Biopharmaceuticals AG 47 non nucleoside inhibitor 47 Saforis 47 rxRNA 47 IMiDs ® compound 47 OraTest 47 rhLF 47 Chemophase 47 Phase IIb trials 47 Technosphere Insulin System 47 QuadraSphere 47 APEX AMI 47 torezolid 47 cangrelor 47 Cethrin 47 HepeX B 47 Abstral ™ 47 TKM PLK1 47 Sphingomab TM 47 eTag assays 47 ANCHOR trial 47 Silenor ® 47 SPRYCEL ® 47 Phase Ib II 47 Pitavastatin 47 bupropion HCl 47 fosbretabulin 47 REVIVE TA 47 recombinant PSMA vaccine 47 rPA anthrax vaccine 47 QT QTc 47 Alzhemed TM 47 4SC commented 47 Cintredekin besudotox 47 PROSTVAC ® 47 Maxy G# 47 ARISE Phase III 47 Technosphere Insulin 47 Pagoclone 47 VitiGam TM 47 seasonal influenza VLP vaccine 47 registrational 47 Tarsa oral calcitonin 47 pain palliation 47 Bioral Amphotericin B 47 EVIZON 47 photoprotective drug 47 cytokine refractory 47 IIa clinical 47 clinical pharmacology studies 47 REMUNE R 47 XOMA 3AB 47 NeoDisc 47 Lucanix R 47 GRALISE 47 pafuramidine maleate 47 Zavesca ® 47 Troxatyl TM 47 OMAPRO 47 Advaxis Phase 47 CytoFab ™ 47 Phase Ia 47 Diamyd r 47 novel therapeutic antibodies 47 bortezomib Velcade 47 ASONEP 47 immatics 47 im peramivir 47 Marketing Authorisation Application MAA 47 MGd 47 TransVax ™ 47 torsemide ER 47 Markit CIPS manufacturing 47 SEASONALE 47 Harry Palmin President 47 faropenem medoxomil 47 CALGB # [002] 47 inflatable penile prosthesis 47 RSR# 47 bardoxolone 47 Neo Kidney Augment 47 forodesine hydrochloride 47 CG# [003] 47 MVA MUC1 IL2 47 ENRICH trial 47 RSD# oral 47 OraQuick ® 47 doxorubicin docetaxel 47 exploratory Phase IIa 47 Behcet uveitis 47 aurora kinase inhibitor 47 Optiquel ™ 47 Visian Toric ICL 47 TRPV1 agonist 47 alicaforsen enema 47 huC# DM4 47 REVIVE Diabetes 47 rhIGF-I/rhIGFBP-3 47 preclinically 47 Selective Electrochemical Tumor Ablation 47 subcutaneous dosing 47 AZX# 47 ENMD # 47 Fodosine 47 VIBEX MTX 47 commercialize DAVANAT ® 47 Martin Nicklasson CEO 47 biomarker assay 47 dermatology biopharmaceutical company 47 GAMMAGARD 47 Initiate Phase II 47 ProMune 47 TKM ApoB 47 non nucleoside HCV 47 Potelligent Technology 47 Traficet EN 47 favorable tolerability 47 BC SeraPro 47 vernakalant hydrochloride 47 PA# [002] 47 Rhucin R 46 miconazole Lauriad 46 Receive Milestone Payment 46 potency selectivity 46 dacetuzumab 46 Phase #/#a clinical 46 Ph3 46 Bema Fentanyl 46 bioabsorbable drug eluting 46 EOquin 46 rilonacept 46 ON #.Na 46 Anticalin R 46 edifoligide E2F Decoy 46 KIACTA ™ 46 pediatric pontine glioma 46 Phase IIB 46 mITT population 46 e2 Collector 46 Fibrostat R 46 PCA3 assay 46 cediranib 46 CLIA waiver 46 investigational antiplatelet 46 CorVue 46 TASKi3 46 IIa trials 46 DEEP AF 46 celgosivir 46 Arisaph 46 Nasdaq MITI 46 apoptosis inducer 46 thorough QT 46 generation purine nucleoside 46 Aryx 46 Prodarsan R 46 JAK#/JAK# inhibitor CYT# 46 oral treprostinil 46 PRECISE trial 46 Tekmira SNALP technology 46 NASDAQ GNTA 46 HGS# 46 vaginally administered lidocaine 46 Triapine R 46 Announces Poster Presentations 46 PROCHYMAL 46 ImmuKnow R 46 drug eluting stent DES 46 PROMACTA 46 BioMatrix TM 46 PRESEPT study 46 HCD# [002] 46 Ceplene TM 46 HuLuc# 46 multi kinase inhibitor 46 CIMZIA TM 46 Zelnorm Zelmac 46 Phase IIa proof 46 Orally administered 46 Prepandrix 46 Squalamine 46 metabolite identification 46 Nasdaq PGNX today 46 Asubio 46 rFVIIa 46 PROCHIEVE 46 orally administered inhibitor 46 PD2i CA 46 Phase III pivotal 46 ORBIT II 46 Nanobody ® 46 REMOXY ® 46 rindopepimut 46 Cytolin 46 samalizumab 46 Pharmacokinetic studies 46 MET inhibitor 46 CVac 46 vascular disrupting agent 46 Intravail R 46 AMPAKINE CX# 46 Phase III Clinical Trials 46 NP2 46 INTEGRILIN 46 Eligen R Technology 46 ChimeriVax JE 46 preclinical pharmacokinetic 46 NOX E# 46 iii GTx 46 FOLFOX regimen 46 Phase 1b clinical trials 46 OvaRex MAb 46 PNP inhibitor 46 tubulin inhibitor 46 OFIRMEV TM 46 RSD# 46 relapsed MM 46 goserelin 46 Provenge prostate cancer 46 PK PD modeling 46 CUSTOM III 46 Nasulin 46 Study NX# 46 tramiprosate ALZHEMED TM 46 CRD5 46 initiate Phase IIb 46 canakinumab 46 OraTest R 46 PROMACTA ® 46 AMPK activators 46 Eniluracil 46 PI3K/Akt pathway inhibitor 46 XERECEPT R 46 Rubicon Filter 46 evaluating Actimmune 46 microdose 46 OXi# 46 ACCLAIM II 46 Phase 1a 46 Zavesca R 45 MVax 45 indibulin 45 pharmacodynamic PD 45 blinded randomized placebo controlled 45 Bevasiranib 45 taxane derivative 45 Manja Bouman CEO 45 fostamatinib 45 relapsed ALL 45 intradermal injections 45 registrational studies 45 FavId 45 trastuzumab emtansine T DM1 45 AIMM trial 45 BeneFIX 45 Ampakine compounds 45 PEARL SC 45 Akt inhibitor 45 ESTRASORB 45 multicenter clinical trials 45 motesanib diphosphate 45 isoform selective 45 Fibrillex TM 45 NASDAQ OSIR 45 anti arrhythmic 45 therapeutic peptide 45 ® natalizumab 45 cortical stimulation 45 StemEx R 45 HCV polymerase 45 pharmacokinetic characteristics 45 pegaptanib 45 Phase Ib IIa clinical 45 subcutaneous immunoglobulin 45 David Spaight 45 AdhTAP 45 BIOCEUTICALS 45 Fc fusion protein 45 IV RSD# 45 IND Investigational New 45 CLL8 45 XmAb# 45 Virulizin ® 45 Cardioxyl Pharmaceuticals 45 indiplon capsules 45 MAXY alpha 45 Ultrafast Insulin 45 Clinicaltrials.gov 45 biomarkers predictive 45 triphendiol 45 demonstrated clinically meaningful 45 Alequel ™ 45 eniluracil 45 stated Michelle Berrey 45 treatmentof 45 hepatitis B vaccine Heplisav 45 Novalar 45 PROSTVAC VF 45 HIV integrase inhibitors 45 Palang Merah Indonesia 45 Telintra 45 visit www.sciclone.com 45 interferon beta therapy 45 ACTEMRA TM 45 Alnylam #x# 45 telaprevir VX 45 SF #v# 45 Anticalin 45 Kenta Biotech 45 lintuzumab SGN 45 TLR agonists 45 evaluating satraplatin 45 Pharmacokinetic parameters 45 immunosuppressant therapies 45 aurora kinase 45 Btk inhibitor 45 Study #CL# 45 Telatinib 45 piperacillin tazobactam 45 CINOD 45 refractory colorectal cancer 45 dasatinib Sprycel 45 Bionutrics 45 TDF FTC 45 Receives Favorable 45 pomalidomide 45 PyratineXR 45 dirucotide 45 targeting PCSK9 45 peak plasma concentrations 45 TriRima 45 obatoclax 45 pharmacodynamics PD 45 Premarket Approval 45 intradermal injection 45 palifermin 45 octreotide implant 45 Luramist 45 TheraCIM h R3 45 vivo toxicology 45 phase Ib clinical 45 JAK2 inhibitor 45 novel VDA molecule 45 refractory CLL 45 MICARDIS ® 45 Hemopurifier ® 45 attain statistical significance 45 mSEPT9 biomarker 45 peptidomimetic 45 Oncotype 45 Dr. Bahcall 45 Isolagen Process 45 opioid bowel dysfunction 45 SURFAXIN r 45 small molecule tyrosine 45 sargramostim 45 IGXT IntelGenx today 45 RIO Lipids 45 pixantrone NDA 45 OVATURE trial 45 CCR5 inhibitor 45 Onko Sure ™ 45 CheckFree eVent TM 45 interferon beta 1b 45 Xcellerated T Cells 45 BETAS 45 Ventrus 45 Somatuline Autogel 44 dose escalation phase 44 demonstrated antitumor activity 44 GED aPC 44 chimeric monoclonal antibody 44 Loramyc ™ 44 eprescribing 44 CELVAPAN H#N# 44 diagnostic prognostic 44 Juvista 44 maturation inhibitor 44 DACH platinum 44 treat premature ejaculation 44 TBC# 44 treatment naive genotype 44 QOPI 44 Pliaglis 44 Phase III randomized controlled 44 Nasdaq PARD biopharmaceutical 44 TRUEtrack 44 elvucitabine 44 Provecta 44 favorable pharmacokinetic profile 44 Red Cross Palang Merah 44 Albuferon Phase 44 Zemiva 44 talactoferrin 44 Preclinical studies suggest 44 Cologuard 44 OncoGenex Technologies 44 Carl Pelzel 44 oral tyrosine kinase 44 antiangiogenic agent 44 microRNA profiling 44 proprietary electroporation 44 lorcaserin Phase 44 dorzolamide 44 pharmacokinetic studies 44 developing calcitonin 44 Oralair R 44 confirmatory pivotal 44 TAXUS TM 44 outlicensing 44 genomic biomarker 44 JAK2 inhibitors 44 CYT# potent vascular disrupting 44 3 registrational trial 44 adrenergic regulation 44 LHRH antagonists 44 Apo AIMilano 44 retaspimycin 44 bolus injection 44 OraQuick R 44 CCR5 antagonist 44 viral kinetics 44 NADiA 44 Ceplene/IL-2 44 commented Alexis Borisy 44 inecalcitol 44 Feasibility Trial 44 cMET inhibitor 44 Shire velaglucerase alfa 44 dosing cohort 44 PEGylated interferon 44 Zmax 44 varespladib 44 Diamyd ® 44 Euronext Brussels ABLX 44 romidepsin 44 MYTHOS trial 44 vilazodone 44 cMET 44 selective modulator 44 Aurora kinase inhibitor 44 blinded randomized 44 buccal delivery 44 molecular imaging radiopharmaceuticals 44 Ostabolin C TM 44 Xerecept 44 IL-#/# 44 Phase 2b randomized 44 vation TA 44 Neurodex TM 44 Inc XNPT 44 ritonavir boosted 44 Orathecin 44 NOXXON 44 thorough QTc 44 Dacogen injection 44 Angioblast 44 SIMPADICO 44 synDNA TM 44 AKT inhibitor 44 isavuconazole 44 CB2 selective 44 EVIZON TM 44 Amplimexon 44 C1 inhibitor rhC1INH 44 liposome formulation 44 #beta estradiol 44 inhaled prostacyclin 44 generation FBPase inhibitor 44 apricitabine ATC 44 EMPOWER Study 44 rotary VAD 44 KYNAPID 44 EvaMist 44 human microdosing 44 NEUGENE antisense 44 MADIT II 44 Confirms Validity 44 Nanobodies 44 intravenous dosing 44 Phase IIa trials 44 treat dysmenorrhea 44 convenient dosing regimens 44 vaginal lidocaine 44 genotypic resistance 44 huN# DM1 44 BROMDAY 44 Loramyc TM 44 JAK inhibitors 44 ARIKACE 44 Microdosing 44 LB# [003] 44 Serdaxin ® 44 clinicaltrials 44 prospectively defined 44 RenalGuard System TM 44 INS# [002] 44 GSK# [001] 44 Phase III HEAT 44 vitro dissolution 44 ZARS 44 Tarek Sherif CEO 44 Acetylon 44 CardioPET 44 HIFU therapy 44 BEZ# 44 TriGrid ™ 44 darunavir r 44 Conformite Europeene 44 RIGScan CR 44 Provent Therapy 44 R roscovitine 44 Phase IIb IIIa 44 HCV antiviral 44 Pierre Fabre Laboratories 44 ofatumumab HuMax CD# 44 Gregory Balestrero president 44 Helicobacter pylori eradication 44 recombinant antithrombin product 44 PMI 44 PhG alpha 1 44 Amoxicillin PULSYS 43 predictive biomarker 43 TRA 2P 43 IgG1 antibodies 43 Caliper Driven 43 RXi proprietary 43 dose cohort 43 TROPOS 43 PEP# Topical 43 PEG SN# 43 Loretta M. Itri 43 ancrod 43 carcinogenicity study 43 SuperAntibody